TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/23 16:03 | 3/14/23 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | Sagartz John E | IN | DO | Chief St | P | 25 | 4.91 | 0 | 5 | 1 | 692 | D | ||||||||||||||
2/17/22 17:18 | 2/17/22 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | Sagartz John E | IN | DO | Chief St | P | 50 | 19.95 | 0 | 3 | 0 | 681 | D | ||||||||||||||
6/8/21 16:10 | 6/7/21 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | Sagartz John E | IN | DO | Chief St | P | 50 | 28.70 | 0 | 2 | 0 | 649 | D | ||||||||||||||
6/1/21 16:01 | 5/27/21 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | Sagartz John E | IN | DO | Chief St | P.m | 50 | 24.78 | 0 | 2 | 0 | 647 | D | ||||||||||||||
8/20/20 16:02 | 8/19/20 | BASI | Bioanalytical Systems Inc | IN | Health | Biolab | Commercial Physical & Biologi | Sagartz John E | IN | DO | Chief St | P | 18 | 4.75 | 0 | 4 | 1 | 634 | D | ||||||||||||||
3/14/19 16:16 | 3/14/19 | BASI | Bioanalytical Systems Inc | IN | Health | Biolab | Commercial Physical & Biologi | Sagartz John E | IN | DT | P | 3 | 1.94 | 0 | 1 | 0 | 622 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |